Your browser doesn't support javascript.
loading
Beyond the BRAFV600E hotspot: biology and clinical implications of rare BRAF gene mutations in melanoma patients.
Richtig, G; Hoeller, C; Kashofer, K; Aigelsreiter, A; Heinemann, A; Kwong, L N; Pichler, M; Richtig, E.
Affiliation
  • Richtig G; Institute of Experimental and Clinical Pharmacology, Medical University of Graz, Graz, Austria.
  • Hoeller C; Department of Dermatology, Medical University of Graz, Graz, Austria.
  • Kashofer K; Department of Dermatology, Medical University of Vienna, Vienna, Austria.
  • Aigelsreiter A; Institute for Pathology, Medical University of Graz, Graz, Austria.
  • Heinemann A; Institute for Pathology, Medical University of Graz, Graz, Austria.
  • Kwong LN; Institute of Experimental and Clinical Pharmacology, Medical University of Graz, Graz, Austria.
  • Pichler M; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, U.S.A.
  • Richtig E; Division of Oncology, Medical University of Graz, Graz, Austria.
Br J Dermatol ; 177(4): 936-944, 2017 Oct.
Article in En | MEDLINE | ID: mdl-28278349

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Proto-Oncogene Proteins B-raf / Melanoma / Mutation Limits: Humans Language: En Journal: Br J Dermatol Year: 2017 Type: Article Affiliation country: Austria

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Proto-Oncogene Proteins B-raf / Melanoma / Mutation Limits: Humans Language: En Journal: Br J Dermatol Year: 2017 Type: Article Affiliation country: Austria